OpenRounds Editorial
Daily Briefing
Sunday, May 3, 2026
What Changed
The American College of Radiology deployed an LLM-powered registry to enforce post-deployment AI governance through automated concordance scoring, while France's prohibition on collecting racial and ethnic data exposes a policy gap that prevents healthcare AI systems from detecting biases against minority populations in clinical deployment [1][2].
Policy & Ops
•[AI in Medical Imaging] The American College of Radiology launched the Assess-AI registry within the National Radiology Data Registry, enabling participating facilities to submit de-identified AI output, radiology report text, and DICOM study metadata through the ACR Connect platform, where central concordance is then computed between AI outputs and LLM-extracted surrogate labels drawn from those reports [1]. The registry gives radiology programs a standardized post-deployment monitoring mechanism that shifts performance validation away from vendor-reported figures toward ongoing operational evidence collected across real sites.
•[AI in Clinical Policy] France's policy prohibiting the collection of race and ethnicity data prevents healthcare AI systems from identifying or correcting biases against African and Afro-descendant populations, according to a Viewpoint published in The Lancet Digital Health [2]. The analysis argues that a framework designed to promote equality through non-distinction paradoxically produces inequality by leaving bias invisible—a governance tension that health systems operating under similar data-collection restrictions will need to resolve before deploying AI tools trained on population-level datasets.
•[AI in Clinical Practice] The FDA is planning to use AI to accelerate clinical trials, according to STAT Health Tech [3]. The agency's move from AI oversight toward AI adoption as an internal operational tool marks a notable shift in how regulators are positioning themselves relative to the technology they govern.
Research
•[AI in Clinical Policy] A proof-of-concept published in JAMIA Open found that Claude 3 Opus achieved 88–98% semantic accuracy extracting 12 of 14 health technology assessment attributes from NICE reports, outperforming both rule-based and classification models and uniquely enabling extraction at the medicine-indication combination level [4]. Regulatory affairs and formulary teams gain a tested starting point for automating HTA data extraction, though the proof-of-concept scope means validation on a broader range of HTA report formats is a necessary next step before production deployment.
•[AI in Medical Imaging] A semi-automated AI system evaluated in Ultrasound Quarterly identifies clinically relevant sonographic features in pediatric lung ultrasound, with researchers pointing to real-time visual annotation as a specific mechanism for supporting trainees who struggle with operator-dependent interpretation [5]. The training application addresses a concrete adoption barrier—inconsistent reads among less-experienced providers—though the study's technical innovation framing means prospective clinical performance data against standard diagnostic reference would strengthen the evidence base.
Industry & Products
•[AI Product Strategy] Genomic sequencing programs can reduce capital and consumable costs for reference-quality telomere-to-telomere assemblies by running the HERRO-Verkko pipeline on Oxford Nanopore R9.4.1 and R10.4.1 Simplex data, eliminating the need to combine multiple sequencing platforms, according to findings published in Nature [6]. The single-platform methodology lowers the DNA input and infrastructure requirements that have made T2T assemblies impractical at scale, offering precision medicine programs a more accessible path to benchmark-quality genomes.
One to Watch
•[AI in Clinical Practice] Researchers introduced a psychologically-grounded graph modeling approach for depression detection from conversational interactions, designed to address the data scarcity and interpretability limitations that constrain current black-box deep learning methods in this space [7]. The framework targets scalable screening applications, but clinical validation on diverse populations and clear integration protocols for behavioral health workflows remain open before the approach moves beyond early signal status.